Joseph E Gilliam

PRESIDENT & COO

Joseph E Gilliam (PRESIDENT & COO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Glaukos Corporation (GKOS). The largest single filing was $10.8M of GKOS (60,000 sh across 2 lots, as filed), executed Aug 11.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$17.2M

shares × price, as filed

Last traded

Aug 11

Filed Aug 13

Median ADV $192.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $18.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

GKOS

Glaukos Corporation GKOS · 0 buys · 7 sells 7 filings

Recent filings

GKOSSALE Glaukos Corporation View filing → $10.8M
60,000 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 7:57 PM ET GKOSSALE Glaukos Corporation View filing → $2.8M
19,573 sh × $143.54
Exec May 1
Filed May 4 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $1.3M
10,498 sh across 4 lots
Exec Jan 22
Filed Jan 26 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $561K
4,502 sh × $124.65
Exec Jan 21
Filed Jan 23 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $1.7M
19,340 sh × $90.00
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $499K
3,328 sh across 2 lots
Exec Dec 20 2024
Filed Dec 23 2024 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $316K
2,275 sh × $138.97
Exec Oct 30 2024
Filed Nov 1 2024 · 5:30 PM ET